GlaxoSmithKline PLC (GSK) — Capital Reinvestment Ratio
GlaxoSmithKline PLC (GSK) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (GBX2.22 Billion) in capital expenditures (GBX879.00 Million). Check GSK tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GlaxoSmithKline PLC Capital Reinvestment Ratio (1990–2024)
This chart tracks GlaxoSmithKline PLC's Capital Reinvestment Ratio across 40 annual periods. For the full cash flow conversion analysis, see GlaxoSmithKline PLC (GSK) cash conversion ratio.
Annual Capital Reinvestment Ratio for GlaxoSmithKline PLC (1990–2024)
Year-by-year Capital Reinvestment Ratio for GlaxoSmithKline PLC from 1990 to 2024. See cash generation quality of GlaxoSmithKline PLC to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | GBX6.55 Billion | GBX2.98 Billion | ▲ +31.4% |
| 2023 | 0.35x | GBX6.77 Billion | GBX2.34 Billion | ▲ +13.5% |
| 2022 | 0.31x | GBX7.40 Billion | GBX2.26 Billion | ▼ -17.2% |
| 2021 | 0.37x | GBX7.95 Billion | GBX2.93 Billion | ▲ +39.0% |
| 2020 | 0.27x | GBX8.44 Billion | GBX2.24 Billion | ▼ -1.6% |
| 2019 | 0.27x | GBX8.02 Billion | GBX2.16 Billion | ▲ +26.5% |
| 2018 | 0.21x | GBX8.42 Billion | GBX1.80 Billion | ▼ -33.0% |
| 2017 | 0.32x | GBX6.92 Billion | GBX2.20 Billion | ▼ -12.1% |
| 2016 | 0.36x | GBX6.50 Billion | GBX2.35 Billion | ▼ -51.1% |
| 2015 | 0.74x | GBX2.57 Billion | GBX1.90 Billion | ▲ +118.7% |
| 2014 | 0.34x | GBX5.18 Billion | GBX1.75 Billion | ▲ +43.6% |
| 2013 | 0.24x | GBX7.22 Billion | GBX1.70 Billion | ▼ -32.2% |
| 2012 | 0.35x | GBX4.38 Billion | GBX1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | GBX6.25 Billion | GBX1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | GBX6.80 Billion | GBX1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | GBX7.84 Billion | GBX1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | GBX7.31 Billion | GBX2.07 Billion | ▼ -23.5% |
| 2007 | 0.37x | GBX5.79 Billion | GBX2.14 Billion | ▼ -7.9% |
| 2006 | 0.40x | GBX3.96 Billion | GBX1.59 Billion | ▲ +90.0% |
| 2005 | 0.21x | GBX5.59 Billion | GBX1.18 Billion | ▲ +295.2% |
| 2004 | 0.05x | GBX4.77 Billion | GBX255.00 Million | ▼ -75.6% |
| 2003 | 0.22x | GBX4.85 Billion | GBX1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | GBX3.06 Billion | GBX1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | GBX4.61 Billion | GBX1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | GBX1.85 Billion | GBX1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | GBX510.00 Million | GBX597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | GBX410.00 Million | GBX475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | GBX615.00 Million | GBX415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | GBX849.00 Million | GBX401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | GBX1.25 Billion | GBX684.00 Million | ▲ +175.5% |
| 1995 | 0.20x | GBX2.45 Billion | GBX485.59 Million | ▲ +0.0% |
| 1994 | 0.20x | GBX2.45 Billion | GBX485.59 Million | ▼ -63.7% |
| 1994 | 0.55x | GBX1.05 Billion | GBX575.00 Million | ▲ +0.0% |
| 1993 | 0.55x | GBX1.05 Billion | GBX575.00 Million | ▼ -16.7% |
| 1993 | 0.66x | GBX927.00 Million | GBX608.00 Million | ▲ +0.0% |
| 1992 | 0.66x | GBX927.00 Million | GBX608.00 Million | ▼ -27.5% |
| 1992 | 0.90x | GBX657.00 Million | GBX594.00 Million | ▲ +0.0% |
| 1991 | 0.90x | GBX657.00 Million | GBX594.00 Million | ▼ -8.2% |
| 1991 | 0.99x | GBX615.00 Million | GBX606.00 Million | ▲ +0.0% |
| 1990 | 0.99x | GBX615.00 Million | GBX606.00 Million | — |